Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1799134

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1799134

Healthcare CMO

PUBLISHED:
PAGES: 174 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Healthcare CMO Market to Reach US$291.1 Billion by 2030

The global market for Healthcare CMO estimated at US$158.7 Billion in the year 2024, is expected to reach US$291.1 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Pharmaceutical CMO, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$185.0 Billion by the end of the analysis period. Growth in the Medical Device CMO segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$43.2 Billion While China is Forecast to Grow at 14.2% CAGR

The Healthcare CMO market in the U.S. is estimated at US$43.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$59.2 Billion by the year 2030 trailing a CAGR of 14.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 9.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Healthcare CMO Market - Key Trends & Drivers Summarized

Why Are Contract Manufacturing Organizations Becoming Integral to Healthcare Supply Chains?

Healthcare Contract Manufacturing Organizations (CMOs) provide outsourced manufacturing services for pharmaceutical products, medical devices, and biologics. These organizations handle complex tasks ranging from formulation and production to packaging and distribution. As healthcare companies face pressure to reduce costs, accelerate time-to-market, and maintain regulatory compliance, CMOs are playing an increasingly central role in production strategies.

CMOs offer access to specialized facilities and technical expertise without requiring capital-intensive infrastructure investments by the healthcare brand owner. This is particularly valuable for small and mid-sized firms developing niche therapies or medical technologies. Larger companies are also leveraging CMOs to increase manufacturing flexibility, manage demand surges, and enter new markets with local production capabilities.

How Are CMOs Expanding Capabilities Across Pharmaceuticals and Medtech?

Pharmaceutical CMOs are enhancing capabilities in high-potency drug production, sterile injectables, and continuous manufacturing. Biologics manufacturing, including monoclonal antibodies and cell therapies, is seeing significant investment in upstream and downstream processing capacity. CMOs are expanding fill-finish services, cold chain logistics, and advanced packaging for sensitive formulations.

In the medical device sector, CMOs are incorporating precision tooling, additive manufacturing, and automation to meet the stringent requirements of surgical, diagnostic, and wearable devices. Electronic component integration, sterilization services, and quality documentation are critical capabilities being scaled up for compliance with international regulatory frameworks. Many CMOs now offer end-to-end services from design assistance to regulatory submissions and post-market support, consolidating their role in product lifecycle management.

Where Is CMO Demand Rising and Which Therapeutic Areas Lead Outsourcing Activity?

Demand for CMO services is rising in North America, Europe, and Asia-Pacific, with regional differences in service specialization and therapeutic focus. Oncology, autoimmune diseases, and rare conditions are key areas driving pharmaceutical outsourcing due to complex manufacturing needs and targeted treatment models. For medical devices, demand is strongest in diagnostics, minimally invasive surgery, and connected health solutions.

Biotech firms with limited in-house infrastructure are increasingly relying on CMOs for both clinical trial materials and commercial-scale production. Established pharma companies are outsourcing mature product lines to CMOs in lower-cost regions to optimize internal resources. In diagnostics, CMOs are supporting rapid scaling of assay kits, reagents, and instrument components in response to global health demands. These patterns are reinforcing CMO relevance across clinical and commercial supply chains.

What Is Driving Growth in the Healthcare CMO Market?

Growth in the healthcare CMO market is driven by several factors related to manufacturing specialization, therapeutic complexity, and supply chain optimization. Rising development of biologics, sterile injectables, and personalized medicines is encouraging use of contract manufacturers with specialized infrastructure. Advances in automation, compliance systems, and high-throughput production are improving operational efficiency and regulatory alignment. Growth is also supported by increased outsourcing of low-margin legacy products, entry of virtual biotech companies, and expansion of global pharmaceutical pipelines. As healthcare firms seek leaner operations and technical scale-up, CMOs are becoming critical production partners across drugs and devices.

SCOPE OF STUDY:

The report analyzes the Healthcare CMO market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Pharmaceutical CMO, Medical Device CMO)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Almac Group
  • AMRI (Albany Molecular Research Inc.)
  • Boehringer Ingelheim BioXcellence
  • Catalent, Inc.
  • CordenPharma International GmbH
  • Emergent BioSolutions Inc.
  • Famar Health Care Services
  • Fareva Group
  • Grifols International S.A.
  • Jubilant Pharmova Ltd.
  • Lonza Group AG
  • Patheon (by Thermo Fisher Scientific)
  • PCI Pharma Services
  • Pfizer CentreOne
  • Piramal Pharma Solutions
  • Recipharm AB
  • Samsung Biologics
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP38895

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Healthcare CMO - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Outsourced Pharmaceutical and Medical Device Manufacturing Drives Growth in Healthcare CMOs
    • Surge in Biologics and Complex Drug Formulations Spurs Demand for Specialized CMO Capabilities in Aseptic and High-Potency Manufacturing
    • Expansion of Small and Virtual Biotech Companies Strengthens Business Case for End-to-End CMO Partnerships
    • Growing Regulatory Complexity Across Global Markets Encourages Reliance on CMOs With Compliance and QA Expertise
    • Increased Focus on Cost Optimization and Time-to-Market Pressures Propel Demand for Flexible, Scalable CMO Services
    • Expanding CDMO (Contract Development and Manufacturing Organization) Models Combine R&D With Scalable Production
    • Growth in Personalized Medicine and Orphan Drug Development Generates Opportunities for Niche and Adaptive CMOs
    • Rising Demand for Fill-Finish, Packaging, and Serialization Services Strengthens CMO Role in Final Drug Product Delivery
    • Technological Advancements in Continuous Manufacturing and PAT Tools Enhance Efficiency and Traceability in CMO Processes
    • Rising Adoption of Subscription-Based and Pay-Per-Use Models Makes Fitness Clubs More Accessible to Price-Sensitive Consumers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Healthcare CMO Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Healthcare CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceutical CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmaceutical CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Pharmaceutical CMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Medical Device CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Medical Device CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Medical Device CMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • JAPAN
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • CHINA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: China 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • EUROPE
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Healthcare CMO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • FRANCE
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: France 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • GERMANY
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Healthcare CMO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • INDIA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: India 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Healthcare CMO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Healthcare CMO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • AFRICA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!